Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × INDUSTRY × SCLC × Clear all

Phase

Phase 1 3 Phase 2 2 Phase 3 1 Phase 2/3 1 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 25 Neoplasms 21 Neoplasm Metastasis 18 Breast Neoplasms 18 Prostatic Neoplasms 14 Stomach Neoplasms 12 Recurrence 12 Colorectal Neoplasms 12 Squamous Cell Carcinoma of Head and Neck 10 Pancreatic Neoplasms 10 Ovarian Neoplasms 10 Lung Neoplasms 10 Head and Neck Neoplasms 10 Myasthenia Gravis 9 Carcinoma, Hepatocellular 9 Urinary Bladder Neoplasms 8 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Melanoma 7 Leukemia, Myeloid, Acute 7 Multiple Myeloma 6 Lymphoma, Non-Hodgkin 6 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma, Follicular 5 Liver Neoplasms 5 Glioblastoma 5 Colonic Neoplasms 5 Carcinoma, Transitional Cell 5 Small Cell Lung Carcinoma 4 Myelodysplastic Syndromes 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07145333 2025-09-08

Drug-SNP

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

SCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡